Charles River Laboratories International (CRL) Cash from Operations (2009 - 2026)

Charles River Laboratories International has reported Cash from Operations for 18 years, with the latest figure at $179.7 million in Q2 2026.

• On a quarterly basis, Cash from Operations fell 12.16% year-over-year to $179.7 million in Q2 2026; TTM through Jun 2026 was $582.1 million, a 26.07% decrease from a year earlier, with the FY2025 full-year figure at $737.6 million, changed 0.42% from the prior year.
• Cash from Operations was $179.7 million for Q2 2026 at Charles River Laboratories International, up from $41.1 million in the prior quarter.
• The five-year high for Cash from Operations was $251.8 million in Q3 2024, with the low at $41.1 million in Q1 2026.
• Average Cash from Operations over 5 years is $166.5 million, with a median of $165.5 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Cash from Operations soared 54.73% in 2023, then tumbled 76.08% in 2026.
• Over 5 years, Cash from Operations stood at $234.8 million in 2022, then retreated by 5.88% to $220.9 million in 2023, then dropped by 27.87% to $159.4 million in 2024, then decreased by 7.43% to $147.5 million in 2025, then gained by 21.83% to $179.7 million in 2026.
• The last three Cash from Operations figures came in at $179.7 million (Q2 2026), $41.1 million (Q1 2026), and $147.5 million (Q4 2025), per Business Quant data.